Comparison of Amiodarone versus Ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation

American Journal of Cardiology

Volumn 90, Issue 5, 2002, Pages 492-495

  Oral, Hakan ^a,b   Özaydin, Mehmet ^a   Tada, Hiroshi ^a   Chugh, Aman ^a   Hassan, Sohail ^a   Scharf, Christoph ^a   Lai, Steve W K ^a   Greenstein, Radmira ^a   Pelosi Jr , Frank ^a   Knight, Bradley P ^a   Strickberger, S Adam ^a   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b F1310 MCHC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; IBUTILIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY VEIN; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; VEIN SURGERY;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CROSS-OVER STUDIES; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; SULFONAMIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036711060     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02520-1     Document Type: Article

References (18)

1. Haissaguerre M., Shah D.C., Jais P., Hocini M., Yamane T., Deisenhofer I., Chauvin M., Garrigue S., Clementy J. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation. 102:2000;2463-2465.
2. Chen S.A., Hsieh M.H., Tai C.T., Tsai C.F., Prakash V.S., Yu W.C., Hsu T.L., Ding Y.A., Chang M.S. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation . Circulation. 100:1999;1879-1886.
3. Oral H., Knight B.P., Tada H., Ozaydin M., Chugh A., Hassan S., Scharf C., Lai S.W., Greenstein R., Pelosi F. Jr, Strickberger S.A., Morady F. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 105:2002;1077-1081.
4. Tada H., Oral H., Wasmer K., Greenstein R., Pelosi F. Jr, Knight B.P., Strickberger S.A., Morady F. Pulmonary vein isolation comparison of bipolar and unipolar electrograms at successful and unsuccessful ostial ablation sites . J Cardiovasc Electrophysiol. 13:2002;13-19.
5. Lau C.P., Tse H.F., Ayers G.M. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol. 33:1999;1217-1226.
6. Shah D.C., Haissaguerre M., Jais P., Hocini M., Yamane T., Deisenhofer I., Garrigue S., Clementy J. Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients strategy for presentations ranging from sustained atrial fibrillation to no arrhythmias . PACE. 24:2001;1541-1558.
7. Sticherling C., Hsu W., Tada H., Bares A., Oral H., Pelosi F., Knight B., Strickberger S., Morady F. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation refractoriness. J Cardiovasc Electrophysiol. 13:2002;151-157.
8. Daoud E.G., Bogun F., Goyal R., Harvey M., Man K.C., Strickberger S.A., Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 94:1996;1600-1606.
9. Daoud E.G., Knight B.P., Weiss R., Bahu M., Paladino W., Goyal R., Man K.C., Strickberger S.A., Morady F. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation. 96:1997;1542-1550.
10. Singh B.N. Antiarrhythmic actions of amiodarone a profile of a paradoxical agent . Am J Cardiol. 78:1996;41-53.
11. Murray K.T. Ibutilide. Circulation. 97:1998;493-497.
12. Scheinman M.M., Levine J.H., Cannom D.S., Friehling T., Kopelman H.A., Chilson D.A., Platia E.V., Wilber D.J., Kowey P.R., The Intravenous Amiodarone Multicenter Investigators Group . Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 92:1995;3264-3272.
13. Oral H., Souza J.J., Michaud G.F., Knight B.P., Goyal R., Strickberger S.A., Morady F. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 340:1999;1849-1854.
14. VanderLugt J.T., Mattioni T., Denker S., Torchiana D., Ahern T., Wakefield L.K., Perry K.T., Kowey P.R. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation. 100:1999;369-375.
15. Glatter K., Yang Y., Chatterjee K., Modin G., Cheng J., Kayser S., Scheinman M.M. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation. 103:2001;253-257.
16. Glatter K.A., Dorostkar P.C., Yang Y., Lee R.J., Van Hare G.F., Keung E., Modin G., Scheinman M.M. Electrophysiological effects of ibutilide in patients with accessory pathways. Circulation. 104:2001;1933-1939.
17. Tse H.F., Lau C.P., Ayers G.M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart. 82:1999;319-324.
18. Pappone C., Rosanio S., Oreto G., Tocchi M., Gugliotta F., Vicedomini G., Salvati A., Dicandia C., Mazzone P., Santinelli V., Gulletta S., Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia a new anatomic approach for curing atrial fibrillation . Circulation. 102:2000;2619-2628.